Contribution of anticholinergic medication to symptom change in schizophrenia.
DeQuardo
J R
JR
Kloss
R J
RJ
D000978:Antiparkinson Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012107:Research Design / Q000592:standards; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012720:Severity of Illness Index; D013888:Thiothixene / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D010276:Parasympatholytics; D013888:Thiothixene